SYS-CON MEDIA Authors: Kevin Benedict, Gilad Parann-Nissany, Michael Bushong, Eric Brown

News Feed Item

Destiny Media Technologies Announces Filing of Global Patents for Cross-Platform Playerless Streaming Technology

VANCOUVER, Feb. 12, 2014 /PRNewswire/ - Destiny Media Technologies (TSXV: DSY) (OTCQX: DSNY), the global standard for the secure distribution of pre-release music to radio and the developer of a new cross-platform playerless video streaming format is pleased to announce that it has filed, and is in the process of filing, patent applications relating to the techniques that power its new Clipstream® cross-platform playerless streaming video technology. These new global applications will rely on an August 2011 priority date set when the original provisional application was filed. Seven patents for this technology are pending in the US.

New applications are being filed in: Australia, Canada, China, Europe, India, Israel, Japan, New Zealand, Russia, South Africa and Singapore.

About Destiny Media Technologies, Inc.

Destiny Media Technologies provides services that enable content owners to securely display and distribute their audio and video content digitally through the internet. The Company's two major services are Clipstream® and Play MPE®. Clipstream® (http://www.clipstream.com) is a video format that plays on any modern smart phone, tablet, internet enabled TV or computer. With Clipstream®, there is no player to configure or install, videos never go obsolete, and there are up to 90% cost savings by reducing the use of transcoding, infrastructure and bandwidth. Play MPE® (http://www.plaympe.com) provides a standardized method to securely and cost effectively distributes pre-release music to radio stations and other music industry professionals, before it is ready for sale. More information can be found at http://www.dsny.com.

SOURCE Destiny Media Technologies, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.